IMS Health Revenue and Competitors
Estimated Revenue & Valuation
- IMS Health's estimated annual revenue is currently $58.9M per year. 0
- IMS Health's total funding is $3.5B.
Employee Data
- 00
IMS Health's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chairman/CEO | Reveal Email/Phone |
2 | Director Production | Reveal Email/Phone |
3 | General Manager Marketing & Communications | Reveal Email/Phone |
4 | Consultant | Reveal Email/Phone |
IMS Health Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.3M | 90 | 7% | N/A | N/A |
#2 | $13.4M | 55 | 6% | N/A | N/A |
#3 | $21.6M | 80 | 7% | N/A | N/A |
#4 | $23.2M | 86 | 48% | N/A | N/A |
#5 | $36.5M | 135 | -6% | N/A | N/A |
#6 | $18M | 74 | 3% | N/A | N/A |
#7 | $35.6M | 132 | 11% | N/A | N/A |
#8 | $9.7M | 45 | 10% | N/A | N/A |
#9 | $28.6M | 106 | 3% | N/A | N/A |
#10 | $9.9M | 46 | 2% | N/A | N/A |
What Is IMS Health?
A new company built from a foundation of deep experience and capabilities. We’re designing our approach to help our clients move healthcare forward. New ways to improve clinical trials. More robust evidence to support treatments. A clearer picture of the patient journey. Insights that actually lead to better commercial performance.
keywords:N/A
$3.5B
Total Funding
N/A
Number of Employees
$58.9M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
IMS Health News
Given the current geopolitical and public health backdrop, ... Cegedim, jointly with IQVIA (formerly IMS Health), is being sued by Euris for...
MOUNTAINSIDE, NJ IQVIA Inc., a multinational healthcare ... In November 2017, Quintiles and IMS Health Inc., merged to form IQVIA.
SCOTTSDALE, Ariz., April 21, 2022 /PRNewswire/ -- Medicx Health is ... Janssen/J&J, IBM, IMS Health/IQVIA and NDCHealth/Symphony Health.
Other Companies in Danbury
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 2 | -33% | N/A |
#2 | $0.2M | 3 | 0% | N/A |
#3 | $0.4M | 3 | 50% | N/A |
#4 | $0.5M | 6 | -14% | N/A |
#5 | $0.4M | 6 | N/A | N/A |